XML 34 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Summary of Option Activity under 2018 Plan, 2013 Plan and 2010 Plan

A summary of option activity under the 2018 Plan, 2013 Plan, and 2010 Plan for the nine months ended September 30, 2020, is as follows:

Year-to-Date Activity

 

Number

of Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Term (Years)

 

 

Aggregate

Intrinsic

Value

(in millions)

 

Options outstanding at December 31, 2019

 

 

1,313,475

 

 

$

12.28

 

 

 

8.7

 

 

 

 

 

Granted

 

 

133,500

 

 

 

3.61

 

 

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

(89,812

)

 

 

11.92

 

 

 

 

 

 

 

 

 

Options outstanding at September 30, 2020

 

 

1,357,163

 

 

 

11.46

 

 

 

7.7

 

 

 

 

Options exercisable at September 30, 2020

 

 

535,848

 

 

$

15.21

 

 

 

6.1

 

 

 

 

Summary of Restricted Stock Unit Activity under 2018 Plan

A summary of restricted stock unit activity under the 2018 Plan for the nine months ended September 30, 2020, is as follows:

Year-to-Date Activity

 

Number

of Shares

 

 

Weighted

Average

Grant Date Fair Value Per Share

 

 

Aggregate

Intrinsic

Value

(in millions)

 

Non-vested outstanding at December 31, 2019

 

 

9,000

 

 

$

23.60

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

Vested/settled

 

 

(5,858

)

 

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

(3,142

)

 

 

 

 

 

 

 

 

Non-vested outstanding at September 30, 2020

 

 

 

 

 

 

 

 

 

Summary of Stock-Based Compensation Expense The amount of stock-based compensation expense recorded to research and development expenses and to general and administrative expenses is detailed in table below:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

115,817

 

 

$

166,289

 

 

$

606,470

 

 

$

785,423

 

General and administrative

 

 

371,586

 

 

 

397,735

 

 

 

1,151,845

 

 

 

1,165,894

 

 

 

$

487,403

 

 

$

564,024

 

 

$

1,758,315

 

 

$

1,951,317